Alembic Pharmaceuticals Schedules Q2 FY27 Post-Results Earnings Conference Call
Alembic Pharmaceuticals Ltd 路 Intimation 路 04 Nov 2026, 4:00 pm
Alembic Pharmaceuticals Schedules Q2 FY27 Post-Results Earnings Conference Call Alembic Pharmaceuticals Limited will host an earnings conference call with its senior management team for analysts and institutional investors on 4th Nov'26 at 4:00 PM IST to discuss its unaudited financial results for Q2 FY27. Participants can join through pre-registration or access the call via universal dial-in numbers (+91 22 6280 1411 / +91 22 7115 8312) alongside international toll-free lines for the USA, UK, Singapore, and Hong Kong.
Original exchange filing (PDF)
More announcements from Alembic Pharmaceuticals Ltd
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Binimetinib Tablets, 15 mg and 45 mg. 路 15 Nov 2026
- Please find attached herewith the Transcript of Post Results Conference Call held on 4th November, 2026. 路 10 Nov 2026
- Alembic Pharmaceuticals Limited receives USFDA Final Approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC). 路 05 Nov 2026
- Please find attached Audio Recording of Investor Call. 路 05 Nov 2026
- Please find attached intimation under Regulation 30(5) of SEBI (LODR) Regulations, 2015. 路 04 Nov 2026
- Please find attached Press Release 路 04 Nov 2026
- Please find attached Investor Presentation for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
- Please find attached Press Release for the Quarter and Half Year Ended September 30, 2026. 路 04 Nov 2026
